Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT01222416

Terminated

PET/CT Evaluation of Treatment Response in Breast Cancer

Breast Cancer
NCT01292200

Completed

Breast Health in Chinese American Women

Breast Cancer
NCT01222052

Unknown

6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients (NNBC3-Europe)

Breast Cancer
NCT01704547

Completed

Breast Cup Immobilization Device II (GCC 1047) (BCID II)

Breast Cancer
NCT02321527

Completed

Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients

Breast Cancer
NCT03186599

Unknown

Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer

Breast Cancer
NCT00041119

Completed

Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

Breast Cancer
NCT00058526

Completed

A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer

Neoplasms, Breast
NCT00896649

Completed

Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer

Breast Cancer
NCT00478686

Completed

Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine

Breast Cancer
NCT01227408

Withdrawn

Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer

Breast Cancer
NCT00863655

Completed

Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole (BOLERO-2)

Breast Cancer
NCT02597179

Unknown

Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer

Breast Cancer
NCT00045032

Completed

Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer (HERA)

Breast Cancer
NCT01488357

Completed

Patient Preferences for Breast Reconstruction After Mastectomy

Breast Cancer
NCT02092636

Completed

Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring

Breast Cancer
NCT00331097

Completed

ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment

Breast Cancer
NCT00993642

Withdrawn

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Breast Cancer
NCT00615901

Completed

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Breast Cancer
NCT00332852

Completed

Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

Breast Cancer
NCT00647218

Completed

Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Breast Cancer
NCT02583568

Completed

Fluorescence Guided Surgery in Breast Cancer (MARGIN)

Breast Cancer
NCT02144194

Unknown

Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca (TNM)

Breast Cancer
NCT00290758

Completed

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Breast Cancer
NCT00330317

Completed

Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

Breast Cancer
NCT00372476

Completed

Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer (INV181)

Breast Cancer
NCT02256670

Completed

Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial

Breast Cancer
NCT00087620

Terminated

A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer

Breast Cancer
NCT02396108

Unknown

Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer

Breast Cancer
NCT02761616

Completed

A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer

Breast Cancer
NCT00491816

Unknown

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

Breast Cancer
NCT02449993

Completed

Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy

Breast Cancer
NCT00068263

Completed

3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection

Breast Cancer
NCT00912444

Terminated

Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer (NATT)

Breast Cancer
NCT00524303

Completed

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

Neoplasms, Breast
NCT02197949

Terminated

Preoperative and Intraoperative Quantification of Axillary Tumoral Load

Breast Cancer
NCT02609373

Completed

Improving Cancer-Related Outcomes in Shift Workers (ICOS)

Breast Cancer
NCT00882674

Completed

A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Breast Cancer
NCT01437566

Completed

Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy

Breast Cancer
NCT00499603

Unknown

Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

Breast Cancer
NCT01479179

Withdrawn

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Breast Cancer
NCT02327572

Completed

Age-related Changes in the Immune System and Their Impact on Elderly Breast Cancer (IMAGE)

Breast Cancer
NCT02111239

Unknown

Preoperative Imaging in DIEP Flap Breast Reconstruction

Breast Cancer
NCT02096185

Unknown

Is Any Additional Information Gained Regarding Margins Using 3D Tomosynthesis Vs 2D Conventional Digital Imaging When Imaging Operative Breast Specimens?

Breast Cancer
NCT01419197

Completed

A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy (TH3RESA)

Breast Cancer
NCT02078570

Unknown

Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

Breast Cancer
NCT00084396

Completed

Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Breast Cancer
NCT00691379

Completed

Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer

Breast Cancer
NCT02355600

Unknown

Oocyte Recovery During Tamoxifen Adjuvant Therapy (TAMOXIFERT)

Breast Cancer
NCT00201708

Completed

Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations